A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity

TH Shin, M Kim, CO Sung, SJ Jang, GS Jeong - Lab on a Chip, 2019 - pubs.rsc.org
Microfluidic devices as translational research tools provide a potential alternative to animal
experiments due to their ability to mimic physiological parameters. Several approaches that …

Microfluidic organoids-on-a-chip: Quantum leap in cancer research

F Duzagac, G Saorin, L Memeo, V Canzonieri… - Cancers, 2021 - mdpi.com
Simple Summary Organoids, also known as self-organized 3D organ-like clusters, represent
almost a physiological system for studying cells, stem cells, tissues, and diseases, especially …

Engineering microfluidic organoid-on-a-chip platforms

F Yu, W Hunziker, D Choudhury - Micromachines, 2019 - mdpi.com
In vitro cell culture models are emerging as promising tools to understand human
development, disease progression, and provide reliable, rapid and cost-effective results for …

Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids

B Schuster, M Junkin, SS Kashaf… - Nature …, 2020 - nature.com
Abstract Three-dimensional (3D) cell culture technologies, such as organoids, are
physiologically relevant models for basic and clinical applications. Automated microfluidics …

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week

Y Hu, X Sui, F Song, Y Li, K Li, Z Chen, F Yang… - Nature …, 2021 - nature.com
While the potential of patient-derived organoids (PDOs) to predict patients' responses to anti-
cancer treatments has been well recognized, the lengthy time and the low efficiency in …

Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer

Z Xu, Y Gao, Y Hao, E Li, Y Wang, J Zhang, W Wang… - Biomaterials, 2013 - Elsevier
Individualized treatment is a promising clinical strategy for lung cancer, and drug sensitivity
testing is fundamental to this scheme. We aimed to develop an effective drug sensitivity test …

Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening

Y Du, X Li, Q Niu, X Mo, M Qui, T Ma… - Journal of Molecular …, 2020 - academic.oup.com
The recent advent of robust methods to grow human tissues as 3D organoids allows us to
recapitulate the 3D architecture of tumors in an in vitro setting and offers a new orthogonal …

[HTML][HTML] Tumor organoids as a pre-clinical cancer model for drug discovery

F Weeber, SN Ooft, KK Dijkstra, EE Voest - Cell chemical biology, 2017 - cell.com
Tumor organoids are 3D cultures of cancer cells that can be derived on an individual patient
basis with a high success rate. This creates opportunities to build large biobanks with …

Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies

Q Luan, JH Becker, C Macaraniag, MG Massad… - Lab on a Chip, 2022 - pubs.rsc.org
There is a growing interest in developing personalized treatment strategies for each cancer
patient, especially those with non-small cell lung carcinoma (NSCLC) which annually …

Organoid cultures as preclinical models of non–small cell lung cancer

R Shi, N Radulovich, C Ng, N Liu, H Notsuda… - Clinical Cancer …, 2020 - AACR
Purpose: Non–small cell lung cancer (NSCLC) is the most common cause of cancer-related
deaths worldwide. There is an unmet need to develop novel clinically relevant models of …